Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by Goldnboy1on Aug 13, 2023 5:55am

233 Views

Post# 35585795

Short interest

Rating 2.49 days to cover.

Meaning based on average trading volumes it would take 2.49 trading days to cover shorts if 100% of volume was short covering.

49% of trades are short. 51% long.

So we have a nice short squeeze brewing here.

If big long buying comes in, it will be extremely expensive for those shorts to cover and they will need to cover fast at that.

Smells like a recipe for this volatility to continue. Except now aggressively back in the upside Vs. The downside.

Monday should be fun!

<< Previous

Bullboard Posts

Next >>

Bombardier reveals NetJets as buyer behind US$6 billion order